PTC Therapeutics
Develops rare-disease medicines spanning PKU, DMD, gene therapy, and RNA-splicing programs.
$70.59
After-hours close+0.51 (+0.73%)
At close$70.08(−2.41%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.28 | — | — |
| Jul 2026 | $0.24 | $0.92 | +289.3% |
| May 2026 | −$0.45 | −$0.03 | +93.3% |
| Feb 2026 | −$0.21 | −$1.67 | −695.2% |
| Nov 2025 | −$1.19 | $0.20 | +116.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | $0.28 | — | — | $302.3M | — | — |
| Jul 30, 2026 | $0.24 | $0.92 | +289.3% | $298.6M | $360.5M | +20.7% |
| May 7, 2026 | −$0.45 | −$0.03 | +93.3% | $217.4M | $272.6M | +25.4% |
| Feb 19, 2026 | −$0.21 | −$1.67 | −695.2% | $279.5M | $164.7M | −41.1% |
| Nov 4, 2025 | −$1.19 | $0.20 | +116.8% | $281.5M | $211.0M | −25.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| Apr 25, 2024 | ||||||
| Feb 29, 2024 | ||||||
| Oct 26, 2023 | ||||||
| Aug 3, 2023 | ||||||
| Apr 27, 2023 | ||||||
| Feb 21, 2023 | ||||||
| Oct 27, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 22, 2022 | ||||||
| Oct 28, 2021 | ||||||
| Jul 29, 2021 | ||||||
| May 4, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Oct 29, 2020 | ||||||
| Aug 5, 2020 | ||||||
| Apr 30, 2020 | ||||||
| Mar 2, 2020 | ||||||
| Oct 29, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 2, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 5, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 9, 2018 | ||||||
| Mar 6, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 8, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Nov 2, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 29, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Jul 30, 2015 | ||||||